102 related articles for article (PubMed ID: 16471040)
1. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
2. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
7. [The activity of cathepsin B in colorectal adenocarcinomas].
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Sulkowski S; Chrzanowska A
Pol Merkur Lekarski; 2001 Oct; 11(64):330-3. PubMed ID: 11770313
[TBL] [Abstract][Full Text] [Related]
8. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Guzińska-Ustymowicz K
Anticancer Res; 2006; 26(2B):1589-94. PubMed ID: 16619576
[TBL] [Abstract][Full Text] [Related]
9. Detection of alkaline sphingomyelinase activity in human stool: proposed role as a new diagnostic and prognostic marker of colorectal cancer.
Di Marzio L; Di Leo A; Cinque B; Fanini D; Agnifili A; Berloco P; Linsalata M; Lorusso D; Barone M; De Simone C; Cifone MG
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):856-62. PubMed ID: 15824156
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical expression of cathepsin D in colorectal cancer.
Valentini AM; Pirrelli M; Armentano R; Caruso ML
Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
[TBL] [Abstract][Full Text] [Related]
14. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
15. [Cathepsin D activity in gastric cancer].
Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
[TBL] [Abstract][Full Text] [Related]
16. Expression of cystatin C in clinical human colorectal cancer tissues.
Saleh Y; Sebzda T; Warwas M; Kopec W; Ziólkowska J; Siewinski M
J Exp Ther Oncol; 2005; 5(1):49-53. PubMed ID: 16416601
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma: correlations with cathepsin D expression and other malignant features.
Kunimura T; Inagaki T; Wada M; Ushio J; Sato K; Enosawa T; Nakashima M; Kato H; Hayashi R; Saitou K; Morohoshi T
Int J Gastrointest Cancer; 2003; 33(2-3):149-54. PubMed ID: 14716064
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.
Linder N; Martelin E; Lundin M; Louhimo J; Nordling S; Haglund C; Lundin J
Eur J Cancer; 2009 Mar; 45(4):648-55. PubMed ID: 19112016
[TBL] [Abstract][Full Text] [Related]
19. [The concentration of HSP 27 in tumour and adjacent distal mucosa in colorectal adenocarcinoma].
Strzelczyk JK; Krakowczyk Ł; Kasperczyk J; Strzelczyk J; Zalewska-Ziob M; Wiczkowski A
Przegl Lek; 2011; 68(5):263-8. PubMed ID: 21961414
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas.
Zhang YG; DU J; Tian XX; Zhong YF; Fang WG
Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
